반응형
한국의료기기협동조합에서는 「 의료기기 국제인증지원센터」사업의 일환으로 SZU KOREA와 함께 최신 규격 정보를 제공하기 위한 세미나를 실시
반응형
의료기기관련기관
「의료기기 국제인증지원센터」Active device 미용목적기기 세미나 개최
2023. 8. 18. 15:25
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.18(금)
2023. 8. 18. 15:23
반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/ 임상시험 |
Bio Pharmaceutical Outsourcing Report | 07-31-2023 |
| Trial Disruptions Due to the Russian Invasion of Ukraine—A Year On | 07-31-2023 | |
| Generative AI Has the Potential to Revolutionize the Pharma Industry by Addressing Drug Discovery Challenges | 08-01-2023 | |
| Setback for Sumitomo and Otsuka’s Ulotaront After Phase III Failure in Schizophrenia | 08-01-2023 | |
| Cyltezo Illustrates the Intersection of Price and Regulation in the Biosimilar Market | 08-01-2023 | |
| Contract Manufacturing: Opportunities and Threats – July 2023 | 08-03-2023 | |
| July Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q3 2023 | 08-03-2023 | |
| First Ever CRISPR-CAS9 Therapy, Exa-Cel, Shows Promising Results | 08-03-2023 | |
| Artificial Intelligence Is Set to Power the Future of Healthcare Provision | 08-08-2023 | |
| Zuranolone Approved for Postpartum Depression but Misses Out on Bigger Major Depressive Disorder Indication | 08-08-2023 | |
| Daiichi Sankyo Secures FDA Nod for Vanflyta as AML Treatment | 08-08-2023 | |
| 질환별 | The NASH Market Holds Untapped Potential | 07-31-2023 |
| Diabetic Macular Edema Seven- Market Drug Forecast and Market Analysis – Update | 07-31-2023 | |
| Bangladesh and the Dengue Vaccine Question | 08-03-2023 | |
| Juvenile Macular Degeneration: Competitive Landscape | 08-04-2023 | |
| Crohn’s Disease Epidemiology Forecast to 2032 | 08-04-2023 | |
| Dyslipidemia: 68-Market Analysis and Sales Forecast | 08-07-2023 | |
| Telehealth Initiative Shows Promising Results for Opioid Addiction Patients | 08-08-2023 | |
| Malaria Vaccination Program Set to Save Lives of Thousands of Children | 08-09-2023 | |
| Cutaneous Squamous Cell Carcinoma (cSCC) Competitive Landscape | 08-10-2023 | |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.27(수) (0) | 2023.10.06 |
|---|---|
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.04(월) (0) | 2023.09.05 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.04(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.21(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.10(월) (0) | 2023.08.18 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.04(금)
2023. 8. 18. 15:22
반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/ 임상시험 |
Results from Phase III trial bring subcutaneous Ocrevus closer to its potential approval | 07-19-2023 |
| Pfizer, Gilead, and GSK Set to Capture 62% of $150 Billion Infectious Diseases Sales | 07-18-2023 | |
| JNJ-2113’s Encouraging Results on Skin Clearance Demonstrates Potential for Psoriasis | 07-24-2023 | |
| Clinical Trials: Precision and Personalized Medicine | 07-26-2023 | |
| Revenue Surge Seen in 15 of the Top 20 Mega and Large Biopharma Companies in 2022 | 07-27-2023 | |
| Promising Results in Phase III Trial for First-Ever TROP2 Therapy for NSCLC | 07-28-2023 | |
| ADC Therapeutics’s Zynlonta Fails Expectations in Phase II Trial for DLBCL Patients | 07-28-2023 | |
| Bernie Sanders Plans More Drug Price Caps as Big Pharma Fights Back | 07-28-2023 | |
| 질환별 | Preventative Measures Set to Battle for RSV Market Domination | 07-19-2023 |
| Risk of Alzheimer’s Disease Is Higher in the Older Black Population | 07-21-2023 | |
| Updated US Pediatric Cancer Estimate Shows Increasing Lymphoid Leukemia Incidence | 07-20-2023 | |
| Battling the Opioid Crisis: NHS’s Action Plan to Curb Addiction in the UK | 07-24-2023 | |
| Post-Traumatic Stress Disorder (PTSD): Competitive Landscape | 07-25-2023 | |
| Primary Immune Deficiency: Competitive Landscape | 07-27-2023 | |
| Researchers Find Potential Association Between Cadmium and Endometriosis | 07-27-2023 | |
| Bone Cancer Trials in 2023 | 07-28-2023 | |
| Dyslipidemia: Seven-Market Drug Forecast and Market Analysis | 07-28-2023 | |
| AmerisourceBergen Is Supporting Integration of H2O Therapeutics’s Parky DTx App Within Healthcare Systems | 07-31-2023 | |
| Spinal Muscular Atrophy: Competitive Landscape | 07-31-2023 | |
| 컨퍼런스/심포지엄/학회 | Conference Organizing Tool – ESC 2023 | 07-27-2023 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 09.04(월) (0) | 2023.09.05 |
|---|---|
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.18(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.21(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.10(월) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 06.09(금) (0) | 2023.08.18 |
[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.21(금)
2023. 8. 18. 15:22
반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/ 임상시험 |
Eli Lilly’s Donanemab Flaunts Strong Clinical Profile in Data Read-out, Ready to Compete with Leqembi | 07-18-2023 |
| Success of FluMist Quadrivalent in UK Unlikely to Be Matched in Japan | 07-17-2023 | |
| CellTrans’s Lantidra Is the First in a Growing Line of Cell Therapies Expected to Personalize Treatment Paradigms in Type 1 Diabetes | 07-12-2023 | |
| BioCardia Submits Japan Application for Leading Product CardiAMP to Treat Ischemic HFrEF | 07-11-2023 | |
| Investor Sentiment Surges for US Companies, with European and APAC Firms Undervalued | 07-06-2023 | |
| Broader Coverage for Eisai/Biogen’s Leqembi Follows Traditional FDA Approval | 07-07-2023 | |
| BioMarin’s Roctavian Becomes the First FDA-Approved Gene Therapy for Severe Hemophilia A | 07-07-2023 | |
| 질환별 | Risk of Chronic Conditions Associated with Heavy Alcohol Intake in Chinese Men | 07-12-2023 |
| Novel Pipeline Therapies to Drive PD Market Across 7MM to $6.4 Billion in 2029 | 07-14-2023 | |
| Domestic Cases of Malaria Confirmed in the US | 07-13-2023 | |
| Autism Spectrum Disorder Competitive Landscape | 07-13-2023 | |
| HTA Outcomes in the 5EU Are Growing at a Rate of 27% With a Deep Commitment to Oncology | 07-12-2023 | |
| Atrial Fibrillation Market Set to Decline at a CAGR of 1.3% Between 2022 and 2032 | 07-12-2023 | |
| Parkinson’s Disease – Seven Market Drug Forecast and Market Analysis – Update | 07-12-2023 | |
| Alcohol Use Disorder: Competitive Landscape | 07-10-2023 | |
| Atrial Fibrillation: 68-Market Analysis and Sales Forecast | 06-27-2023 | |
| More Children Diagnosed with Type 1 Diabetes Post COVID-19 Pandemic | 07-10-2023 | |
| 컨퍼런스/심포지엄/학회 | Highlights from the EHA Congress 2023 Meeting: Allogeneic Cell Therapy Updates | 06-14-2023 |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.18(금) (0) | 2023.08.18 |
|---|---|
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 08.04(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 07.10(월) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 06.09(금) (0) | 2023.08.18 |
| [KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.26(금) (0) | 2023.08.18 |